Johnson & Johnson
Recent News About Johnson & Johnson View More
-
J&J opting to put $6.5B settlement offer to claimant vote could end long-running talc products litigation
HOUSTON – Johnson & Johnson’s recent decision to put a $6.5 billion settlement offer to a vote by claimants in its long-running litigation over ovarian cancer injuries resulting from use of its talc-based products, may see the case end and a quicker financial recovery for plaintiffs.